Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Your Daily Pharma Scoop: Gemphire Zooms, Trevena Succeeds, Arsanis Falters [Seeking Alpha]

GEMPHIRE THERAPEUTICS INC COMMON (GEMP) 
Last gemphire therapeutics inc common earnings: 5/9 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.gemphire.com
Company Research Source: Seeking Alpha
Summary Stocks in News: GEMP, TRVN Gemphire Therapeutics +58% after meets primary endpoint Discussion : Gemphire Therapeutics’ ( GEMP ) candidate Gemcabene met its Phase 2b primary endpoint in hypertriglyceridemia patients. The company reported significant reduction of up to 47% in patients against 27% for placebo-treated group. This drug candidate is the first oral therapy targeted at ~3.5M patients in the U.S. whose LDL-C or triglyceride level needs to be brought down to avoid further risk of developing acute pancreatitis. Following the announcement, the company’s share price almost doubled in yesterday’s morning trade itself. In spite of the apparently massive surge of 58% ( now 97%), the stock has reached only halfway mark of its 52-wk range. Additionally, the drug also showed a solid safety and tolerability profile and could be safely used as a drug combination. The candidate’s method matent in Severe Hypertriglyceridemia (‘SHTG) is valid until 2032. Various li Show less Read more
Impact Snapshot
Event Time:
GEMP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for GEMP alerts
Opt-in for
GEMP alerts

from News Quantified
Opt-in for
GEMP alerts

from News Quantified